164 related items for PubMed ID: 26328649
21. Low-density lipoprotein apheresis for recurrent focal segmental glomerulosclerosis post renal transplant in pediatric patients.
Al-Mousily MF, Nicoara O, Selewski DT, Nadig S, Twombley K.
J Clin Apher; 2022 Aug; 37(4):411-414. PubMed ID: 35238425
[Abstract] [Full Text] [Related]
22. Liposorber® LA-15 system for LDL apheresis in resistant nephrotic syndrome patients.
Al-Mousily M, Nicoara O, Selewski DT, Twombley K.
Pediatr Nephrol; 2022 Mar; 37(3):585-592. PubMed ID: 34453196
[Abstract] [Full Text] [Related]
23. Complete remission of the nephrotic syndrome due to focal glomerular sclerosis achieved with low density lipoprotein adsorption alone.
Yokoyama K, Sakai S, Yamaguchi Y, Suzuki Y, Hinoshita F, Hara S, Yamada A, Ogura Y, Kawaguchi Y, Sakai O.
Nephron; 1996 Mar; 72(2):318-20. PubMed ID: 8684548
[No Abstract] [Full Text] [Related]
24. Low density lipoprotein apheresis therapy for steroid-resistant nephrotic syndrome. Kansai-FGS-Apheresis Treatment (K-FLAT) Study Group.
Muso E, Mune M, Fujii Y, Imai E, Ueda N, Hatta K, Imada A, Miki S, Kuwahara T, Takamitsu Y, Takemura T, Tsubakihara Y.
Kidney Int Suppl; 1999 Jul; 71():S122-5. PubMed ID: 10412754
[Abstract] [Full Text] [Related]
25. Therapy-resistant focal and segmental glomerulosclerosis.
Kveder R.
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v34-7. PubMed ID: 12817066
[Abstract] [Full Text] [Related]
26. Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children.
Ehrich JH, Pape L, Schiffer M.
Paediatr Drugs; 2008 Jul; 10(1):9-22. PubMed ID: 18162004
[Abstract] [Full Text] [Related]
27. Successful Treatment of Nephrotic Syndrome Due to Collapsing Focal Segmental Glomerulosclerosis Accompanied by Acute Interstitial Nephritis.
Shima H, Doi T, Okamoto T, Higashiguchi Y, Harada M, Inoue T, Tashiro M, Wariishi S, Takamatsu N, Kawahara K, Okada K, Minakuchi J.
Intern Med; 2022 Jun 15; 61(12):1863-1867. PubMed ID: 34803098
[Abstract] [Full Text] [Related]
28. Updated evidence of beneficial effect of LDL apheresis for refractory nephrotic syndrome due to a variety of causative diseases for nationwide and global approval.
Muso E, Kakita H, Suzuki H, Tsukamoto T.
Ther Apher Dial; 2023 Dec 15; 27(6):987-999. PubMed ID: 37593995
[Abstract] [Full Text] [Related]
29. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
Rong LP, Chen LZ, Fu Q, Chen WF, Sun LZ, Jiang XY, Mo Y.
Zhonghua Er Ke Za Zhi; 2016 Dec 02; 54(12):936-940. PubMed ID: 27938596
[Abstract] [Full Text] [Related]
30. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys.
Feld SM, Figueroa P, Savin V, Nast CC, Sharma R, Sharma M, Hirschberg R, Adler SG.
Am J Kidney Dis; 1998 Aug 02; 32(2):230-7. PubMed ID: 9708606
[Abstract] [Full Text] [Related]
31. A case report of plasmapheresis and cyclophosphamide for steroid-resistant focal segmental glomerulosclerosis: recovery of renal function after five months on dialysis.
Oliveira L, Wang D, McCormick BB.
Ther Apher Dial; 2007 Jun 02; 11(3):227-31. PubMed ID: 17498006
[Abstract] [Full Text] [Related]
32. [Steroid-resistant focal segmental glomerulosclerosis treated with cascade plasmafiltration and rituximab].
Tatangelo P, Londrino F, Di Vasta G, Guido G, Centi A, Dominijanni S, Bernabei E, Caramiello MS, Di Franco D, Palumbo R.
G Ital Nefrol; 2018 May 02; 35(3):. PubMed ID: 29786187
[Abstract] [Full Text] [Related]
33. Recurrent nephrotic syndrome after living-related renal transplantation resistant to plasma exchange: report of two cases.
Masutani K, Katafuchi R, Ikeda H, Yamamoto H, Motoyama K, Sugitani A, Kanai H, Kumagai H, Hirakata H, Tanaka M, Iida M.
Clin Transplant; 2005 May 02; 19 Suppl 14():59-64. PubMed ID: 15955171
[Abstract] [Full Text] [Related]
34. Relapsing Guillain Barré Syndrome and nephrotic syndrome secondary to focal segmental glomerulosclerosis.
Souayah N, Cros D, Stein TD, Chong PS.
J Neurol Sci; 2008 Jul 15; 270(1-2):184-8. PubMed ID: 18325535
[Abstract] [Full Text] [Related]
35. Urinary liver-type fatty acid-binding protein levels for differential diagnosis of idiopathic focal glomerulosclerosis and minor glomerular abnormalities and effect of low-density lipoprotein apheresis.
Nakamura T, Sugaya T, Kawagoe Y, Ueda Y, Osada S, Koide H.
Clin Nephrol; 2006 Jan 15; 65(1):1-6. PubMed ID: 16429835
[Abstract] [Full Text] [Related]
36. Thrombotic microangiopathy as a complication in a patient with focal segmental glomerulosclerosis.
Benz K, Amann K, Dittrich K, Dötsch J.
Pediatr Nephrol; 2007 Dec 15; 22(12):2125-8. PubMed ID: 17882457
[Abstract] [Full Text] [Related]
37. Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
Muso E.
Clin Exp Nephrol; 2014 Apr 15; 18(2):286-90. PubMed ID: 24535024
[Abstract] [Full Text] [Related]
38. Extracorporeal Therapies in the Treatment of Focal Segmental Glomerulosclerosis.
Raina R, Wang J, Sharma A, Chakraborty R.
Blood Purif; 2020 Apr 15; 49(5):513-523. PubMed ID: 32074606
[Abstract] [Full Text] [Related]
39. Focal segmental glomerular sclerosis recurrence with massive proteinuria and anuria immediately after kidney transplantation.
Maruyama M, Kitamura H, Akutsu N, Otsuki K, Hasegawa M, Aoyama H, Matsumoto I, Saigo K, Asano T.
Nephrology (Carlton); 2015 Jul 15; 20 Suppl 2():93-5. PubMed ID: 26031597
[Abstract] [Full Text] [Related]
40. Long-term evaluation of children with nephrotic syndrome and focal segmental glomerular sclerosis.
Tejani A, Nicastri AD, Sen D, Chen CK, Phadke K, Adamson O, Butt KM.
Nephron; 1983 Jul 15; 35(4):225-31. PubMed ID: 6358923
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
